Showing results (1-10 of 22) with videos related to
Sort By:
Pageof 3
Current Opinion in Endocrinology, Diabetes, and Obesity|January 11, 2008
Peptide YYKeval Chandarana, Rachel BatterhamNature Medicine|May 8, 2012
Shedding pounds after going under the knife: metabolic insights from cutting the gutKeval Chandarana, Rachel L BatterhamThe Journal of Physiology|December 10, 2008
The role of peptide YY in appetite regulation and obesityEfthimia Karra, Keval Chandarana, Rachel L BatterhamDiabetes, Obesity & Metabolism|June 24, 2017
Insulin degludec/liraglutide (IDegLira) was effective across a range of dysglycaemia and body mass index categories in the DUAL V randomized trialIldiko Lingvay, Stewart Harris, Elmar Jaeckel, et al.Diabetes, Obesity & Metabolism|January 27, 2017
Safety and efficacy of IDegLira titrated once weekly versus twice weekly in patients with type 2 diabetes uncontrolled on oral antidiabetic drugs: DUAL VI randomized clinical trialStewart B Harris, Győző Kocsis, Rudolf Prager, et al.Journal of Clinical Medicine|April 30, 2021
Real-World Outcomes of Ivacaftor Treatment in People with Cystic Fibrosis: A Systematic ReviewJamie Duckers, Beth Lesher, Teja Thorat, et al.Pulmonary Therapy|April 29, 2021
Long-Term Impact of Ivacaftor on Healthcare Resource Utilization Among People with Cystic Fibrosis in the United StatesTeja Thorat, Lisa J McGarry, Krutika Jariwala-Parikh, et al.Pulmonary Therapy|June 8, 2021
Real-World Long-Term Ivacaftor for Cystic Fibrosis in France: Clinical Effectiveness and Healthcare Resource UtilizationDominique Hubert, Christophe Marguet, Jacques Benichou, et al.Gastroenterology|February 24, 2009
Subject standardization, acclimatization, and sample processing affect gut hormone levels and appetite in humansKeval Chandarana, Megan E Drew, Julian Emmanuel, et al.Molecular Metabolism|September 20, 2013
Peripheral activation of the Y2-receptor promotes secretion of GLP-1 and improves glucose toleranceKeval Chandarana, Cigdem Gelegen, Elaine E Irvine, et al.Pageof 3